Home The Word Brain Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

OLIENA
Language recovery after stroke
App | Video | PDF (278 pp) | Web

Free Abstracts

  Hepatitis C

  Free Subscription


01.01.2018

2 Am J Gastroenterol
1 Clin Res Hepatol Gastroenterol
1 Enferm Infecc Microbiol Clin
1 Eur J Gastroenterol Hepatol
1 Gastroenterology
1 Hepatology
1 J Hepatol
1 J Immunol
6 J Viral Hepat
1 PLoS One
1 Proc Natl Acad Sci U S A
1 Transfusion
1 Transplantation


  Retrieve available abstracts of this week’s articles:
HTML format
Text format
 
 
Single Articles


    Am J Gastroenterol

  1. NGUYEN MH, Trinh H, Do S, Nguyen T, et al
    Open Label Study of 8 vs. 12 Weeks of Ledipasvir/Sofosbuvir in Genotype 6 Treatment Naive or Experienced Patients.
    Am J Gastroenterol. 2017;112:1824-1831.
    PubMed     Text format     Abstract available

  2. WU T, Kwok RM, Tran TT
    Isolated anti-HBc: The Relevance of Hepatitis B Core Antibody-A Review of New Issues.
    Am J Gastroenterol. 2017 Oct 31. doi: 10.1038/ajg.2017.
    PubMed     Text format     Abstract available


    Clin Res Hepatol Gastroenterol

  3. NAJAFI FARD S, Schietroma I, Corano Scheri G, Giustini N, et al
    Direct-acting antiviral therapy enhances total CD4+ and CD8+ T-cells responses, but does not alter T-cells activation among HCV mono-infected, and HCV/HIV-1 co-infected patients.
    Clin Res Hepatol Gastroenterol. 2017 Dec 23. pii: S2210-7401(17)30262.
    PubMed     Text format     Abstract available


    Enferm Infecc Microbiol Clin

  4. REQUENA-HERRERA MP, Bedoya-Ismodes EO, Soto A
    Hepatic safety of maraviroc in HIV-1-infected patients with hepatitis C and/or B co-infection.
    Enferm Infecc Microbiol Clin. 2017 Dec 15. pii: S0213-005X(17)30372.
    PubMed     Text format    


    Eur J Gastroenterol Hepatol

  5. ROULOT D, Thibault V, Laforest C, Fontaine H, et al
    Efficacy of daclatasvir-based quadruple therapy in nonresponder patients infected by hepatitis C virus genotype 4: the ANRS HC32 QUATTRO study.
    Eur J Gastroenterol Hepatol. 2017 Dec 21. doi: 10.1097/MEG.0000000000001035.
    PubMed     Text format     Abstract available


    Gastroenterology

  6. GOTTWEIN JM, Pham LV, Mikkelsen LS, Ghanem L, et al
    Efficacy of NS5A Inhibitors Against Hepatitis C Virus Genotypes 1-7 and Escape Variants.
    Gastroenterology. 2017 Dec 21. pii: S0016-5085(17)36720.
    PubMed     Text format     Abstract available


    Hepatology

  7. GRAKOUI A, Walker CM
    Of mice, rats and men: Small animal model of hepatitis C virus infection.
    Hepatology. 2017 Dec 27. doi: 10.1002/hep.29765.
    PubMed     Text format    


    J Hepatol

  8. SCOTT N, Olafsson S, Gottfreethsson M, Tyrfingsson T, et al
    Modelling the elimination of hepatitis C as a public health threat in Iceland: a goal attainable by 2020.
    J Hepatol. 2017 Dec 20. pii: S0168-8278(17)32528.
    PubMed     Text format     Abstract available


    J Immunol

  9. MENDEZ-LAGARES G, Lu D, Chen C, Terrault N, et al
    Memory T Cell Proliferation before Hepatitis C Virus Therapy Predicts Antiviral Immune Responses and Treatment Success.
    J Immunol. 2017 Dec 20. pii: jimmunol.1701364. doi: 10.4049/jimmunol.1701364.
    PubMed     Text format     Abstract available


    J Viral Hepat

  10. MCNAUGHTON AL, Sreenu VB, Wilkie G, Gunson R, et al
    Prevalence of mixed genotype hepatitis C virus infections in the UK as determined by genotype-specific PCR and deep sequencing.
    J Viral Hepat. 2017 Dec 23. doi: 10.1111/jvh.12849.
    PubMed     Text format     Abstract available

  11. KOZUKA R, Hai H, Motoyama H, Hagihara A, et al
    The Presence of Multiple NS5A RASs is Associated with the Outcome of Sofosbuvir and Ledipasvir Therapy in NS5A Inhibitor-Naive Patients with Chronic HCV Genotype 1b Infection in a Real-World Cohort.
    J Viral Hepat. 2017 Dec 23. doi: 10.1111/jvh.12850.
    PubMed     Text format     Abstract available

  12. HAJARIZADEH B, Grebely J, Matthews GV, Martinello M, et al
    Uptake of direct acting antiviral treatment for chronic hepatitis C in Australia.
    J Viral Hepat. 2017 Dec 23. doi: 10.1111/jvh.12852.
    PubMed     Text format     Abstract available

  13. SULKOWSKI MS, Feld JJ, Lawitz E, Felizarta F, et al
    Efficacy and safety of 6 or 8 weeks of simeprevir, daclatasvir, sofosbuvir for HCV genotype 1 infection.
    J Viral Hepat. 2017 Dec 23. doi: 10.1111/jvh.12853.
    PubMed     Text format     Abstract available

  14. EL KASSAS M, Funk AL, Salaheldin M, Shimakawa Y, et al
    Increased recurrence rates of hepatocellular carcinoma after DAA therapy in a hepatitis C infected Egyptian cohort: a comparative analysis.
    J Viral Hepat. 2017 Dec 23. doi: 10.1111/jvh.12854.
    PubMed     Text format     Abstract available

  15. GUBAY F, Staunton R, Metzig C, Abubakar I, et al
    Assessing uncertainty in the burden of Hepatitis C Virus: comparison of estimated disease burden and treatment costs in the UK.
    J Viral Hepat. 2017 Dec 23. doi: 10.1111/jvh.12847.
    PubMed     Text format     Abstract available


    PLoS One

  16. LU G, Huang J, Yang Q, Xu H, et al
    Identification and genetic characterization of hepacivirus and pegivirus in commercial equine serum products in China.
    PLoS One. 2017;12:e0189208.
    PubMed     Text format     Abstract available


    Proc Natl Acad Sci U S A

  17. MANKOWSKI MC, Kinchen VJ, Wasilewski LN, Flyak AI, et al
    Synergistic anti-HCV broadly neutralizing human monoclonal antibodies with independent mechanisms.
    Proc Natl Acad Sci U S A. 2017 Dec 18. pii: 1718441115.
    PubMed     Text format     Abstract available


    Transfusion

  18. GALEL SA, Simon TL, Williamson PC, AuBuchon JP, et al
    Sensitivity and specificity of a new automated system for the detection of hepatitis B virus, hepatitis C virus, and human immunodeficiency virus nucleic acid in blood and plasma donations.
    Transfusion. 2017 Dec 17. doi: 10.1111/trf.14457.
    PubMed     Text format     Abstract available


    Transplantation

  19. GARCIA CR, Acosta LF, Mei X, Berger J, et al
    Liver Transplantation for the Treatment of Complicated Iatrogenic Biliary Injuries: A National Review from the UNOS Dataset.
    Transplantation. 2017 Aug 22. doi: 10.1097/TP.0000000000001922.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Hepatitis C is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: